- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.39 Clinical Research Agreement
- 21 List of Subsidiaries
- 23.1 Consent of Bdo Seidman, LLP
- 23.2 Report of Independent Registered Public Accounting Firm
- 23.3 Consent of Grant Thornton LLP
- 23.4 Report of Independent Registered Public Accounting Firm
- 31.1 Section 302 Cert. - CEO
- 31.2 Section 302 Cert. - CFO
- 32.1 Section 906 Cert. - CEO
- 32.2 Section 906 Cert. - CFO
- 99.3 Financial Statement Schedule
Exhibit 23.4
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ON
FINANCIAL STATEMENT SCHEDULE
Board of Directors and Shareholders
Mannatech, Incorporated
We have audited in accordance with the standards of the Public Company Accounting Oversight Board (United States) the consolidated financial statements of Mannatech, Incorporated and subsidiaries referred to in our report dated March 16, 2007, which is included in the annual report to shareholders and included in Part II of this form. Our audits of the basic financial statements included the financial statement schedule listed in the index appearing under Item 15 for 2005 and 2006, which is the responsibility of the Company’s management. In our opinion, this financial statement schedule, when considered in relation to the basic financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
/s/ Grant Thornton LLP
Dallas, Texas
March 17, 2008